The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle.
about
The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3GThe tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif proteinCellular microRNAs up-regulate transcription via interaction with promoter TATA-box motifsHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHIV-1 Vif, APOBEC, and intrinsic immunityThe HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradationStructural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assemblyThe SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complexCharacterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase componentsStructural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloBMolecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region.Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded VifIdentification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.Phages and HIV-1: from display to interplay.Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.Structural insights for HIV-1 therapeutic strategies targeting Vif.Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell countOn the solution conformation and dynamics of the HIV-1 viral infectivity factorAnti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllersIdentification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteinsHydrodynamic and functional analysis of HIV-1 Vif oligomerization.Gene therapy progress and prospects: novel gene therapy approaches for AIDS.APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10Host restriction factors in retroviral infection: promises in virus-host interaction.APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.Advances in the structural understanding of Vif proteinsTumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.The relative levels of translin-associated factor X (TRAX) and testis brain RNA-binding protein determine their nucleocytoplasmic distribution in male germ cells.HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors
P2860
Q21245195-57641485-1822-44CC-B7DD-6766220E1980Q24291013-1CDA58C7-BC2F-43FC-B14C-C8844E837E0BQ24306122-40A59DC5-214C-49B5-96F2-D1FCEA3E31FCQ24619114-6A21B483-5DD0-45F8-AF46-DA2A94EDFC9DQ24647833-92FD2D9B-BD39-4304-A6F7-0C5C65068F79Q24657375-F2A49080-06AA-4B98-95E3-1A704DEA6A4EQ24658171-F6FC6F9A-5713-4680-BA48-C97BD824951AQ28474177-DC734BD5-C8C5-40A1-AD9C-B64BF3DB0ADDQ28482052-4B9A5569-C8B1-4FB6-BB7B-4A3018FF583DQ28540150-9E496245-81D6-4540-919C-7C0620BC92BFQ30496853-03D43676-A904-4EA4-A42D-CF2BE2208C7EQ33289183-040BBBDE-A477-4838-9020-0266E409A745Q33556837-A37BF536-69D7-4151-84E3-2EA976E32FE0Q33654949-4A79C3DB-8601-4C0E-9DD4-AB1A4FD851D7Q33815187-2D053DEE-11BA-4070-8DA7-206AC2738277Q33826857-AA24839F-A030-4906-9679-67439B2658FEQ34055413-59A7D103-5A95-41DF-9475-B7F4174F3A8DQ34179686-C242AF02-21BF-498C-915A-0A35D71FAF64Q34261416-062E9EF6-BEF3-4A44-84AF-6C2C90D383E3Q34266485-45B8FD92-7934-4049-92B5-0D1E71BEC87FQ34273397-8D803089-ACE0-4DD5-8DC4-3E655586410FQ34312616-E2B7E28D-E7D3-4DFE-9417-4DD4EFEEFAA2Q34345408-99D9CB34-A6A5-4608-8FEE-24E25FAB865EQ34433647-910B8D32-D556-40B8-B656-E05013E39330Q34465108-80AC6DD1-9E8A-4F76-9791-2E20507B71BBQ34665129-44189986-4977-4C37-AC3E-803AB13C9C19Q35113711-288D83D1-E861-496C-AA33-FA100D5C6316Q35489088-8BEE7DB3-8114-4041-A075-3773D40B1CD7Q35531709-3591A3AB-DF9D-488A-9342-790E15B09262Q35827946-4B0C739E-D120-4640-B50C-5298EDCF2A9FQ36036704-B0D032B3-ED4C-4BD1-84E6-B4BC624A72E8Q36216069-8E06B23F-92B7-4F7E-9CCE-01BA1912B40AQ36548179-12F302B0-782C-4FBD-9F08-76705820D3D4Q36827236-D0AEE436-48CE-4AEA-959A-7197F31E3BAAQ37108363-8872709D-DF53-4A5E-8436-479875383B84Q37504507-744C9F4C-5760-4588-9418-21D000F69B61Q37950254-C5AFBF58-087B-4C55-BD50-62FF1EA538DAQ38337622-02571DBA-7967-42FA-9A30-F1FA5A4548E1Q38341321-E773FD89-FF2F-42F3-BEA1-68FCFBA59D68Q39463408-0567AA42-77C5-4E3B-85E2-F4A48608C30C
P2860
The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The multimerization of human i ...... ction in the viral life cycle.
@en
type
label
The multimerization of human i ...... ction in the viral life cycle.
@en
prefLabel
The multimerization of human i ...... ction in the viral life cycle.
@en
P2093
P2860
P356
P1476
The multimerization of human i ...... ction in the viral life cycle.
@en
P2093
P2860
P304
P356
10.1074/JBC.M004895200
P407
P577
2000-11-08T00:00:00Z